Event Brief
Dec 18, 2025 at 6:01 AM ET
Medline stock is too expensive to buy post IPO
By The BriefBrief
Jim Cramer reviewed Medline, a medical supplies giant, after its IPO.
WHO: Jim Cramer
WHAT: Reviewed Medline's stock post IPO
WHEN: Dec 17, 2025 at 7:00 PM ET
WHERE: CNBC
WHY: To assess the stock's value after market debut
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21433 of 21433
Same format. Every time.
Continue reading — sign in or create a free account with
